Aquestive Therapeutics Cash from Financing (TTM) Insights

Aquestive Therapeutics Inc (AQST)

4.07 +0.14 (+3.56%) USD | NASDAQ | Apr 26, 16:00

3.97 -0.10 (-2.46%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	3.974M
September 30, 2023	0.295M
June 30, 2023	-4.822M
March 31, 2023	1.089M
December 31, 2022	11.59M
September 30, 2022	16.81M
June 30, 2022	23.03M
March 31, 2022	21.52M
December 31, 2021	30.11M
September 30, 2021	53.15M
June 30, 2021	47.06M
March 31, 2021	38.38M
December 31, 2020	28.46M

Date	Value
September 30, 2020	39.04M
June 30, 2020	52.68M
March 31, 2020	52.17M
December 31, 2019	49.60M
September 30, 2019	10.45M
June 30, 2019	62.08M
March 31, 2019	56.84M
December 31, 2018	58.04M
September 30, 2018	57.55M
June 30, 2018	-7.758M
March 31, 2018	-2.027M
December 31, 2017	4.414M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-4.822M

Minimum

Jun 2023

62.08M

Maximum

Jun 2019

28.25M

Average

28.46M

Median

Dec 2020

Cash from Financing (TTM) Benchmarks